One-Third Of Serious CAR-T Cell Therapy Side Effects Linked To Toxicity
A third of admissions to ICU by CAR-T therapy patients is linked to toxicity side effects, according to the findings of a new study.
A third of admissions to ICU by CAR-T therapy patients is linked to toxicity side effects, according to the findings of a new study.
The FDA has approved Actemra for use in some children, despite concerns over heart problems, infections and other health risks.
Actemra side effects may cause more bleeding in rheumatoid arthritis patients during knee replacement surgery, a new study warns.
This is the list of the top 10 drug warnings and side effects of 2017, including warnings about breast implant cancer risks, gadolinium contrast agents and other unexpected complications.
U.K. regulators say Actemra is unfit for use in the treatment of giant cell arthritis because it is too expensive.
A new study looking at the uses and side effects of Actemra, Enbrel and Rituxan suggests that observational studies may be a better predictor of drug effectiveness and safety than…
The FDA has expanded the use of Actemra for the treatment of side effects of CAR-T cell therapy amid growing concerns over the drug's potential side effects.
Actemra is being tested in an ongoing clinical trial as a potential treatment for systemic sclerosis, despite growing concerns linking the drug to heart attacks, strokes, and deaths.
A new study looking at the use of Actemra to treat giant cell arthritis indicates that 15% of patients could suffer severe side effects.
New research indicates that some patients taking Actemra to treat rheumatoid arthritis may be more susceptible to severe infections than others.